Literature DB >> 31635476

Machine learning-based unenhanced CT texture analysis for predicting BAP1 mutation status of clear cell renal cell carcinomas.

Burak Kocak1, Emine Sebnem Durmaz2, Ozlem Korkmaz Kaya3, Ozgur Kilickesmez1.   

Abstract

BACKGROUND: BRCA1-associated protein 1 (BAP1) mutation is an unfavorable factor for overall survival in patients with clear cell renal cell carcinoma (ccRCC). Radiomics literature about BAP1 mutation lacks papers that consider the reliability of texture features in their workflow.
PURPOSE: Using texture features with a high inter-observer agreement, we aimed to develop and internally validate a machine learning-based radiomic model for predicting the BAP1 mutation status of ccRCCs.
MATERIAL AND METHODS: For this retrospective study, 65 ccRCCs were included from a public database. Texture features were extracted from unenhanced computed tomography (CT) images, using two-dimensional manual segmentation. Dimension reduction was done in three steps: (i) inter-observer agreement analysis; (ii) collinearity analysis; and (iii) feature selection. The machine learning classifier was random forest. The model was validated using 10-fold nested cross-validation. The reference standard was the BAP1 mutation status.
RESULTS: Out of 744 features, 468 had an excellent inter-observer agreement. After the collinearity analysis, the number of features decreased to 17. Finally, the wrapper-based algorithm selected six features. Using selected features, the random forest correctly classified 84.6% of the labelled slices regarding BAP1 mutation status with an area under the receiver operating characteristic curve of 0.897. For predicting ccRCCs with BAP1 mutation, the sensitivity, specificity, and precision were 90.4%, 78.8%, and 81%, respectively. For predicting ccRCCs without BAP1 mutation, the sensitivity, specificity, and precision were 78.8%, 90.4%, and 89.1%, respectively.
CONCLUSION: Machine learning-based unenhanced CT texture analysis might be a potential method for predicting the BAP1 mutation status of ccRCCs.

Entities:  

Keywords:  Artificial intelligence; clear cell renal cell carcinoma; machine learning; radiogenomics; radiomics; texture analysis

Year:  2019        PMID: 31635476     DOI: 10.1177/0284185119881742

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  8 in total

Review 1.  Machine Learning for Renal Pathologies: An Updated Survey.

Authors:  Roberto Magherini; Elisa Mussi; Yary Volpe; Rocco Furferi; Francesco Buonamici; Michaela Servi
Journal:  Sensors (Basel)       Date:  2022-07-01       Impact factor: 3.847

Review 2.  Radiogenomics in Clear Cell Renal Cell Carcinoma: A Review of the Current Status and Future Directions.

Authors:  Sari Khaleel; Andrew Katims; Shivaram Cumarasamy; Shoshana Rosenzweig; Kyrollis Attalla; A Ari Hakimi; Reza Mehrazin
Journal:  Cancers (Basel)       Date:  2022-04-22       Impact factor: 6.575

Review 3.  Background, applications and challenges of radiogenomics in genitourinary tumor.

Authors:  Longfei Liu; Xiaoping Yi; Can Lu; Yingxian Pang; Xiongbing Zu; Minfeng Chen; Xiao Guan
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

Review 4.  Radiomics to better characterize small renal masses.

Authors:  Teele Kuusk; Joana B Neves; Maxine Tran; Axel Bex
Journal:  World J Urol       Date:  2021-01-26       Impact factor: 4.226

Review 5.  The application of radiomics in predicting gene mutations in cancer.

Authors:  Yana Qi; Tingting Zhao; Mingyong Han
Journal:  Eur Radiol       Date:  2022-01-20       Impact factor: 5.315

6.  Change and consistency in Acta Radiologica over 100 years.

Authors:  Mats Geijer; Henrik S Thomsen
Journal:  Acta Radiol       Date:  2021-10-22       Impact factor: 1.990

Review 7.  The Next Paradigm Shift in the Management of Clear Cell Renal Cancer: Radiogenomics-Definition, Current Advances, and Future Directions.

Authors:  Nikhil Gopal; Pouria Yazdian Anari; Evrim Turkbey; Elizabeth C Jones; Ashkan A Malayeri
Journal:  Cancers (Basel)       Date:  2022-02-04       Impact factor: 6.639

8.  Development and Validation of a Radiomic Nomogram for Predicting the Prognosis of Kidney Renal Clear Cell Carcinoma.

Authors:  Ruizhi Gao; Hui Qin; Peng Lin; Chenjun Ma; Chengyang Li; Rong Wen; Jing Huang; Da Wan; Dongyue Wen; Yiqiong Liang; Jiang Huang; Xin Li; Xinrong Wang; Gang Chen; Yun He; Hong Yang
Journal:  Front Oncol       Date:  2021-07-06       Impact factor: 6.244

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.